Ginkgo Bioworks Holdings (DNA) Other Non-Current Liabilities (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Other Non-Current Liabilities readings, the most recent being $22.9 million for Q4 2025.

  • On a quarterly basis, Other Non-Current Liabilities rose 38.01% to $22.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $22.9 million, a 38.01% increase, with the full-year FY2025 number at $22.9 million, up 38.01% from a year prior.
  • Other Non-Current Liabilities hit $22.9 million in Q4 2025 for Ginkgo Bioworks Holdings, up from $17.2 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $212.9 million in Q3 2021 to a low of $12.3 million in Q3 2023.
  • Median Other Non-Current Liabilities over the past 5 years was $24.7 million (2023), compared with a mean of $45.9 million.
  • Biggest five-year swings in Other Non-Current Liabilities: soared 1087.07% in 2021 and later tumbled 81.34% in 2022.
  • Ginkgo Bioworks Holdings' Other Non-Current Liabilities stood at $36.0 million in 2021, then fell by 13.34% to $31.2 million in 2022, then decreased by 21.67% to $24.4 million in 2023, then plummeted by 32.16% to $16.6 million in 2024, then skyrocketed by 38.01% to $22.9 million in 2025.
  • The last three reported values for Other Non-Current Liabilities were $22.9 million (Q4 2025), $17.2 million (Q3 2025), and $17.9 million (Q2 2025) per Business Quant data.